MedPath

ENALAPRIL MALEATE/HCTZ

ENALAPRIL MALEATE/HCTZ

Approved
DIN Number

02352923

Drug Class

Human

Market Date

Feb 24, 2011

Company
HC

aa pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352923
AIG Number0217290002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09BA02 ENALAPRIL AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.04
Health Canada Classification

ACTIVE INGREDIENTS (2)

ENALAPRIL MALEATEActive
Strength: 5 MG
Monograph: ENALAPRIL MALEATE
HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.